The TKIs brivanib [13, 14], sunitinib [13, 15–17], and vatalanib [15, 18] showed both direct inhibition of ABC transporters and/or efficacy against ABC transporters-expressing cancer cell lines. The gene discussed is ABCG2; the disease is cancer.